Can a simple eye drop slow down worsening nearsightedness in kids?
NCT ID NCT07164092
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests whether low-dose atropine eye drops (0.05%) can slow the progression of myopia (nearsightedness) in children. Forty-five kids with worsening myopia will receive one drop of atropine in one eye and a placebo drop in the other eye every night for 24 months. The main goal is to see if the treated eye has less lengthening of the eyeball, which is linked to myopia progression.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
atropine 0.05% eye drops
What this could lead to
If it works, this could offer a simple, low-cost way to slow worsening nearsightedness in children, reducing their risk of severe vision problems later.
What could go wrong
This is a small, early-phase trial with only 45 children. The results may not apply to all kids, and atropine can cause side effects like light sensitivity or blurry near vision.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYOPIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••